All locations will be closing at 4 p.m due to the weather.

CBD Studies Database - CBD + Children

Cannabinoids in Pediatrics Summary: This study reviews the history of marijuana use and legislation in the United States in addition to the currently available medical literature in order to equip pediatric health care providers with resources to provide patients and their parents with the best recommendations for safe and appropriate use of cannabis-containing compounds.
Read the full study here
 
Examining cannabidiol use in children
Summary: This study examines the evidence relating to the safety and therapeutic benefit of CBD for pediatric patients, and offers suggestions as to how pediatricians should respond to inquiries from parents regarding its use.
Read the full study here. 
 
Medical cannabinoids may benefit children, long-term risks unclear
Summary: This study performed a systematic review of literature that included 21 articles detailing 22 studies with 795 participants in order to analyze the uses of cannabinoids to treat children.
Read the full study here. 
 
Use of cannabidiol oil in children
Summary: This study examines the effectiveness of cannabidiol in young children in the Netherlands for common reasons such as impulsive behavior, itchiness, epilepsy, stress, pain, and sleeping problems.
Read the full study here. 
 
The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children
Summary: This study investigates the therapeutic effects of CBD as well as its risks, quality standards, and labeling practices for children. 
Read the full study here. 
 
Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
Summary: This study reports interim results on the safety and efficacy of CBD in patients with treatment-resistant epilepsies in expanded access programs.
Read the full study here. 
 
A dose ranging safety and pharmacokinetic study of cannabidiol (CBD) in children with Dravet syndrome (GWPCARE1)
Summary: This controlled study evaluated dose-ranging safety, tolerability, and pharmacokinetics of supplemental CBD in children ages 4-10 with Dravet syndrome and then determined the dosage that assessed the safety and efficacy in a larger population.
Read the full study here. 
 
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study
Summary: This observational study evaluates the efficacy of CBD-enriched medical cannabis for the treatment of refractory epilepsy. According to parental reports, results suggest that adding CBD-enriched cannabis extract to the treatment regimen of patients with refractory epilepsy may result in a significant reduction in seizure frequency.
Read the full study here. 
 
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Summary: This study evaluates cannabidiol as a possible adjuvant treatment of refractory epilepsy in children testing drug-drug interactions with clobazam.
Read the full study here.
.
.